INTRAMETICS Platform Candidates
Oncology (multiple cancers driven by IDPs)
Discovery/Pre-clinicalActive
Key Facts
Indication
Oncology (multiple cancers driven by IDPs)
Phase
Discovery/Pre-clinical
Status
Active
Company
About IDP Pharma
IDP Pharma is a private, pre-clinical biotech focused on developing first-in-class drugs for intrinsically disordered proteins (IDPs), which represent a vast, untapped therapeutic target space linked to major diseases like cancer. The company's core innovation is the INTRAMETICS™ platform, which designs advanced peptidomimetics capable of directly binding to and degrading IDPs, overcoming traditional druggability challenges. With a seasoned leadership team and scientific advisory board, IDP Pharma is positioning itself at the forefront of a new modality in drug discovery, aiming to open therapeutic routes for conditions with high unmet medical need.
View full company profile